Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies.

Rev Esp Quimioter · 2023 · PMC10336315 · PMID 37089055

Europe PMC DOI

hedged sentence

0.1600

closest p · 3.2× alpha

0.1600

boldest claim

The sentences

did not reach statistical significancep = 0.16not close (p > 0.1)

15.3% in the comparator cohort, but differences after adjusting for age did not reach statistical significance (OR 0.49, 95% CI 0.18-1.32, p = 0.16).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.